Ocular Therapeut
(OCUL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,023 | -44,703 | -31,881 | -22,285 | -10,840 |
| Depreciation Amortization | 272 | 1,067 | 801 | 565 | 309 |
| Accounts receivable | 6 | -57 | -50 | -30 | -34 |
| Accounts payable and accrued liabilities | 659 | -159 | -289 | -462 | 79 |
| Other Working Capital | -638 | 2,076 | 368 | -261 | -109 |
| Other Operating Activity | 1,147 | 7,775 | 4,662 | 3,415 | 1,339 |
| Operating Cash Flow | $-14,577 | $-34,001 | $-26,389 | $-19,058 | $-9,256 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,654 | -1,917 | -1,237 | -370 | -127 |
| Purchase Of Investment | -3,000 | -41,699 | -14,000 | -11,500 | 0 |
| Sale Of Investment | 12,500 | 80,684 | 64,684 | 50,000 | 25,000 |
| Other Investing Activity | 0 | 0 | -1,500 | -1,500 | 0 |
| Investing Cash Flow | $7,846 | $37,068 | $47,947 | $36,630 | $24,873 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,700 | N/A | 0 | 0 | 0 |
| Debt Repayment | -1,300 | N/A | 0 | 0 | 0 |
| Common Stock Issued | 26,274 | 1,104 | 281 | 203 | 5 |
| Other Financing Activity | -197 | -519 | -389 | -389 | -194 |
| Financing Cash Flow | $28,477 | $585 | $-108 | $-186 | $-189 |
| Beginning Cash Position | 34,664 | 31,012 | 30,784 | 30,784 | 30,784 |
| End Cash Position | 56,410 | 34,664 | 52,234 | 48,170 | 46,212 |
| Net Cash Flow | $21,746 | $3,652 | $21,450 | $17,386 | $15,428 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,577 | -34,001 | -26,389 | -19,058 | -9,256 |
| Capital Expenditure | -1,654 | -1,919 | -1,239 | -370 | -127 |
| Free Cash Flow | -16,231 | -35,920 | -27,628 | -19,428 | -9,383 |